-
EP2808340
European procedure
Extract from the Register of European Patents
EP About this file: EP2808340
| EP2808340 - RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION [Right-click to bookmark this link] | Status | Patent revoked Status updated on 05.01.2022 Database last updated on 03.04.2025 | |
| Former | The patent has been granted Status updated on 13.11.2018 | Most recent event Tooltip | 07.01.2022 | Revocation of patent | published on 09.02.2022 [2022/06] | Applicant(s) | For all designated states Ferring B.V. Polaris Avenue 144 2132 JX Hoofddorp / NL | [2014/49] | Inventor(s) | 01 /
Cottingham, Ian Ferring International Center S.A. Ch. de la Vergognausaz 50 1162 Saint-Prex / CH | 02 /
Plaksin, Daniel Ferring International Center S.A. Ch. de la Vergognausaz 50 1162 Saint-Prex / CH | 03 /
White, Richard, Boyd 1348 Sutter Street San Diego, CA 92103 / US | [2014/49] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2014/49] | Bates, Philip Ian Reddie & Grose LLP 16 Theobalds Road London WC1X 8PL / GB | Application number, filing date | 14178729.1 | 16.04.2009 | [2014/49] | Priority number, date | US20080045424P | 16.04.2008 Original published format: US 45424 P | EP20080251528 | 25.04.2008 Original published format: EP 08251528 | [2014/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2808340 | Date: | 03.12.2014 | Language: | EN | [2014/49] | Type: | B1 Patent specification | No.: | EP2808340 | Date: | 17.08.2016 | Language: | EN | [2016/33] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.11.2014 | Classification | IPC: | C07K14/59, A61K38/24, A61K38/00 | [2014/49] | CPC: |
C07K14/59 (EP,CN,KR,RU,US);
A61K38/24 (KR,RU);
A61P15/00 (EP);
A61P15/08 (EP);
A61P5/06 (EP,RU);
A61P5/10 (EP);
C07K14/575 (KR);
C12N15/09 (KR);
C12N9/1081 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2014/52] | Title | German: | RECOMBINANTES FSH MIT ALPHA 2,3- AND ALPHA 2,6-SIALYLIERUNG | [2014/49] | English: | RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION | [2014/49] | French: | FSH RECOMBINANTE COMPRENANT LA SIALYLATION ALPHA 2,3 ET ALPHA 2,6 | [2014/49] | Examination procedure | 13.11.2014 | Amendment by applicant (claims and/or description) | 13.11.2014 | Examination requested [2014/52] | 13.02.2015 | Despatch of a communication from the examining division (Time limit: M08) | 16.10.2015 | Reply to a communication from the examining division | 19.01.2016 | Despatch of a communication from the examining division (Time limit: M04) | 27.01.2016 | Reply to a communication from the examining division | 17.06.2016 | Communication of intention to grant the patent | 29.06.2016 | Fee for grant paid | 29.06.2016 | Fee for publishing/printing paid | 29.06.2016 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09733497.3 / EP2268666 | EP13193214.7 / EP2722339 | Opposition(s) | Opponent(s) | 01
15.05.2017
ADMISSIBLE Merck Serono S.A. Centre Industriel 1267 Coinsins / CH Opponent's representative Weickmann & Weickmann PartmbB, et al, et al Postfach 860 820 81635 München / DE | [2017/25] | deleted | Deletion: Legal effect of rejection of opposition [ N /P ] | 26.06.2017 | Invitation to proprietor to file observations on the notice of opposition | 06.11.2017 | Reply of patent proprietor to notice(s) of opposition | 12.09.2018 | Date of oral proceedings | 14.11.2018 | Despatch of minutes of oral proceedings | 14.11.2018 | Date of despatch of rejection of opposition | 23.12.2021 | Despatch of communication that the patent will be revoked | 02.01.2022 | Legal effect of revocation of patent [2022/06] | Appeal following opposition | 09.01.2019 | Appeal received No. T0110/19 | 13.03.2019 | Statement of grounds filed | 20.12.2021 | Result of appeal procedure: revocation of the patent | 23.12.2021 | Despatch of the decision of the Board of Appeal | Fees paid | Renewal fee | 28.07.2014 | Renewal fee patent year 03 | 28.07.2014 | Renewal fee patent year 04 | 28.07.2014 | Renewal fee patent year 05 | 28.07.2014 | Renewal fee patent year 06 | 10.04.2015 | Renewal fee patent year 07 | 11.04.2016 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 17.08.2016 | MC | 17.08.2016 | MK | 17.08.2016 | MT | 16.04.2017 | [2019/52] |
| Former [2019/47] | CY | 17.08.2016 | |
| MC | 17.08.2016 | ||
| MT | 16.04.2017 | ||
| Former [2018/43] | MC | 17.08.2016 | |
| MT | 16.04.2017 | ||
| Former [2018/06] | MC | 17.08.2016 | Documents cited: | Search | [A]WO03035686 (APPLIED RESEARCH SYSTEMS [NL], et al); | [T]WO2012016576 (GLYCOTOPE GMBH [DE], et al); | Opposition | WO9831826 | WO03035686 | WO2005080585 | WO2009127826 | WO2012168680 |